Carl Kim

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations”.

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

The Oncologist(2025)10.1093/oncolo/oyaf362

N/A

0.307DataRank · unranked

6 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Clinical and translational study of ivosidenib plus nivolumab in advanced solid tumors harboring IDH1 mutations

medRxiv(2025)10.1101/2025.07.19.25331848

N/A

0.279DataRank · unranked

5 citations

Mark Jelinek, Arjun Singh, Brian R. Isett, Erica S. Myers, Steven J. Mullett +23 more

Integrating artificial intelligence-driven digital pathology and genomics to establish patient-derived organoids as new approach methodologies for drug response in head and neck cancer

Oral Oncology(2025)10.1016/j.oraloncology.2025.107742

N/A

0DataRank · unranked

11 citations

Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more

Integrating Artificial Intelligence-Driven Digital Pathology and Genomics to Establish Patient-Derived Organoids as a Novel Alternative Model for Drug Response in Head and Neck Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.24.660824

N/A

0DataRank · unranked

2 citations

Jie Chen, Carl Kim, Joshua D. Smith, Micah Harris, Krishna B. Singh +24 more